ENFORCER
Dead / Cancelled — Cancelled — Section 8 (as of 21 Aug 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88461039
- Registration number
- 5981450
- Mark type
- Stylized text
- Filed
- 05 Jun 2019
- Published for opposition
- 26 Nov 2019
- Registered
- 11 Feb 2020
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; providing medical and scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies
Owner
- INCYTE HOLDINGS CORPORATION, Wilmington, DE, US
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
- MorphoSys AG, Planegg, DE
Prosecution history
- 21 Aug 2026 — CANCELLED SEC. 8 (6-YR)
- 31 Jul 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 31 Jul 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 31 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Apr 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY